Richard Drake to Proteomics
This is a "connection" page, showing publications Richard Drake has written about Proteomics.
Connection Strength
3.418
-
Mass Spectrometry Imaging of Fibroblasts: Promise and Challenge. Expert Rev Proteomics. 2021 06; 18(6):423-436.
Score: 0.637
-
MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma. Proteomics. 2014 Apr; 14(7-8):924-35.
Score: 0.382
-
Challenges to developing proteomic-based breast cancer diagnostics. OMICS. 2011 May; 15(5):251-9.
Score: 0.309
-
In-depth proteomic analyses of direct expressed prostatic secretions. J Proteome Res. 2010 May 07; 9(5):2109-16.
Score: 0.293
-
Proteomic expression profiling and identification of serum proteins using immobilized trypsin beads with MALDI-TOF/TOF. J Proteome Res. 2009 Sep; 8(9):4182-92.
Score: 0.279
-
Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease. J Proteomics. 2009 Aug 20; 72(6):907-17.
Score: 0.268
-
Proteomics for biodefense applications: progress and opportunities. Expert Rev Proteomics. 2005 Apr; 2(2):203-13.
Score: 0.206
-
New Views of Old Proteins: Clarifying the Enigmatic Proteome. Mol Cell Proteomics. 2022 07; 21(7):100254.
Score: 0.169
-
Zonal regulation of collagen-type proteins and posttranslational modifications in prostatic benign and cancer tissues by imaging mass spectrometry. Prostate. 2020 09; 80(13):1071-1086.
Score: 0.149
-
Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma. PLoS One. 2016; 11(4):e0154074.
Score: 0.111
-
Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine. J Proteome Res. 2012 Apr 06; 11(4):2386-96.
Score: 0.083
-
Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients. J Am Coll Surg. 2009 May; 208(5):970-8; discussion 978-80.
Score: 0.068
-
Proteomic approach to breast cancer. Cancer Control. 2007 Oct; 14(4):360-8.
Score: 0.061
-
Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol Cell Proteomics. 2006 Oct; 5(10):1957-67.
Score: 0.056
-
SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology. 2005 Mar; 41(3):634-42.
Score: 0.051
-
Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer. 2004 May 01; 100(9):1814-22.
Score: 0.048
-
Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status. Proteomics. 2004 Mar; 4(3):826-38.
Score: 0.048
-
Collagen fiber regulation in human pediatric aortic valve development and disease. Sci Rep. 2021 05 07; 11(1):9751.
Score: 0.039
-
Multiplexed Imaging Mass Spectrometry of Histological Staining, N-Glycan and Extracellular Matrix from One Tissue Section: A Tool for Fibrosis Research. Methods Mol Biol. 2021; 2350:313-329.
Score: 0.038
-
Proteomic Profiling of Serial Prediagnostic Serum Samples for Early Detection of Colon Cancer in the U.S. Military. Cancer Epidemiol Biomarkers Prev. 2017 05; 26(5):711-718.
Score: 0.029
-
Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer. Nat Commun. 2016 06 28; 7:11906.
Score: 0.028
-
Cryopreservation of viable human lung tissue for versatile post-thaw analyses and culture. In Vivo. 2014 Jul-Aug; 28(4):411-23.
Score: 0.024
-
Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012. Mol Cell Proteomics. 2013 Oct; 12(10):2935-51.
Score: 0.023
-
Molecular pathology of prostate cancer. Cancer Biomark. 2010; 9(1-6):441-59.
Score: 0.018